Related Experiment Video
Updated: Oct 30, 2025

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS).
Monika Niehof1, Stella Marie Reamon-Buettner2, Olga Danov2
1Department of Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Nikolai-Fuchs-Str. 1, Hannover, 30625, Germany. monika.niehof@item.fraunhofer.de.
This study presents a modified RNA isolation protocol for human precision cut lung slices (PCLS). The improved method enables reliable miRNA analysis, crucial for understanding respiratory diseases and developing new therapies.
Area of Science:
- Biomedical research
- Molecular biology
- Drug discovery
Background:
- Human precision cut lung slices (PCLS) are valuable ex vivo models for lung research.
- MicroRNAs (miRNAs) are key regulators in respiratory diseases and potential biomarkers.
- Standard RNA extraction from PCLS is challenging due to high agarose content.
Purpose of the Study:
- To modify an existing RNA isolation protocol for PCLS.
- To enable efficient and reliable miRNA extraction from PCLS.
- To validate the utility of PCLS for miRNA-based lung disease research.
Main Methods:
- Modification of a published RNA isolation protocol.
- Separation of lysis and precipitation steps.
- Utilizing magnetic beads for a clean-up procedure.
Main Results:
- Successful isolation of high-quality miRNA from PCLS.
- Isolated miRNA is suitable for downstream applications like RTqPCR and transcriptome analysis.
- miRNA profiles from PCLS correlate with known disease-associated miRNAs in IPF, COPD, asthma, and lung cancer.
Conclusions:
- The modified protocol effectively isolates miRNA from PCLS.
- PCLS are a suitable model for studying miRNA biomarkers in lung diseases.
- This method supports advancements in lung disease diagnostics and therapeutics.

